Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper.

Creative Commons License

Klimek L., Jutel M., Bousquet J., Agache I., Akdis C. A., Hox V., ...Daha Fazla

Allergy, cilt.76, ss.677-688, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 76
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1111/all.14629
  • Dergi Adı: Allergy
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.677-688
  • Anahtar Kelimeler: biologics, chronic rhinosinusitis, COVID-19, CRSwNP, SARS-CoV-2, ENDOSCOPIC SINUS SURGERY, NASAL POLYPOSIS, ALLERGIC RHINITIS, GERMAN SOCIETY, ASTHMA, CORTICOSTEROIDS, EXACERBATIONS, ASSOCIATION, INTOLERANCE, PREVALENCE
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

BackgroundChronic rhinosinusitis is regarded as a chronic airway disease. According to WHO recommendations, it may be a risk factor for COVID-19 patients. In most CRSwNP cases, the inflammatory changes affecting the nasal and paranasal mucous membranes are type-2 (T2) inflammation endotypes.